Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Medical coding : what it is and how it works / / Patricia Aalseth
| Medical coding : what it is and how it works / / Patricia Aalseth |
| Autore | Aalseth Patricia |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Burlington, Massachusetts : , : Jones & Bartlett Learning, , 2015 |
| Descrizione fisica | 1 online resource (189 pages) |
| Disciplina | 616.001/2 |
| Soggetto topico |
Nosology
Clinical medicine Health insurance claims |
| ISBN | 1-284-05458-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Medical coding in history -- Diagnosis coding -- Procedure coding -- How codes are used for reimbursement -- Coding for dollars -- Solving your healthcare coding problems -- Coding as a career. |
| Record Nr. | UNINA-9910165026003321 |
Aalseth Patricia
|
||
| Burlington, Massachusetts : , : Jones & Bartlett Learning, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New-opathies [[electronic resource] ] : an emerging molecular reclassification of human disease / / [edited by] Errol C. Friedberg ... [et al.]
| New-opathies [[electronic resource] ] : an emerging molecular reclassification of human disease / / [edited by] Errol C. Friedberg ... [et al.] |
| Pubbl/distr/stampa | New Jersey, : World Scientific, c2012 |
| Descrizione fisica | 1 online resource (310 p.) |
| Disciplina | 616.001/2 |
| Altri autori (Persone) | FriedbergErrol C |
| Soggetto topico |
Diseases
Medical genetics Nosology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-283-59369-6
9786613906144 981-4355-69-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Preface; Acknowledgements; List of Contributors; Chapter 1 Laminopathies William T. Dauer and Howard J.Worman; NEW "OPATHIES" FOR A NEW MILLENNIUM; THE NUCLEAR ENVELOPE: NORMAL STRUCTURE AND COMPOSITION; LAMINOPATHIES; Laminopathies Caused by Mutations in LMNA; Striated muscle diseases; Lipodystrophy syndromes; Peripheral neuropathy; Progeroid syndromes; Laminopathies Caused by Mutations Affecting B-Type Lamins; Mutations in Genes Encoding Nuclear Membrane Proteins; Inner nuclear membrane; Perinuclear space; Outer nuclear membrane
Mutations in Genes Encoding Nuclear Pore Complex ProteinsCONCLUSION; REFERENCES; Chapter 2 Inflammasomopathies: Diseases Linked to the NLRP3 Inflammasome Dominic De Nardo, Johanna Vogelhuber, Larisa Labzin, Pia Langhoff and Eicke Latz; INTRODUCTION AND OVERVIEW; THE NLRP3 INFLAMMASOME: A PLATFORM FOR MATURATION OF IL-1 βFAMILY CYTOKINES; NOD-Like Receptors (NLRs); Inflammasome-Forming Proteins; Focus on the NLRP3 Inflammasome; INFLAMMASOMOPATHIES: THE NLRP3 INFLAMMASOME AND DISEASE; Genetic NLRP3 Inflammasome Disorders; Cryopyrin-associated periodic syndromes (CAPS) Clinical manifestation of CAPS diseasesFamilial cold autoinflammatory syndrome (FCAS); Muckle-Wells syndrome (MWS); Neonatal onset multisystem inflammatory disease (NOMID); Genetics of CAPS; Mechanism of inflammasome activation in CAPS; The NLRP3 Inflammasome and Environmental Diseases; Silicosis and asbestosis; Nanoparticles; The NLRP3 Inflammasome in Infectious Diseases; Influenza A virus; Malaria; The NLRP3 Inflammasome in Metabolic Diseases; Gout and pseudogout; Alzheimer's disease; Atherosclerosis; Obesity and early type 2 diabetes (T2D); Type 2 diabetes progression CURRENT THERAPEUTIC STRATEGIES TARGETING INFLAMMASOMOPATHIESCONCLUDING REMARKS; REFERENCES; Chapter 3 Amyloidosis Morie A. Gertz; INTRODUCTION; PATHOGENESIS; AMYLOID ORGAN INVOLVEMENT; DIAGNOSIS; SCREENING FOR AMYLOIDOSIS; CONFIRMING THE DIAGNOSIS; IMAGING OF AMYLOIDOSIS; CLINICAL CLASSIFICATIONS OF AMYLOIDOSIS; Immunoglobulin Light Chain Amyloidosis (AL); Secondary Systemic Amyloidosis (AA); Familial Amyloidosis; Transthyretin; Nontransthyretin Forms of Familial Amyloidosis; Native Transthyretin Amyloidosis (Senile Cardiac Amyloidosis); Localized Amyloidosis Amyloidosis of the Renal Pelvis, Ureter, Bladder, and UrethraTracheobronchial Tree and Laryngeal Amyloid; SKIN; THERAPY; Treatment Overview; Alkylator-based Therapy; Stem Cell Transplantation; Novel-Agent-Containing Regimens; Thalidomide; Lenalidomide; Bortezomib; Pomalidomide; THERAPY OF SECONDARY AMYLOIDOSIS; TRANSPLANTATION FOR FAMILIAL AMYLOIDOSIS; AGENTS THAT DESTABILIZE THE AMYLOID PROTEIN STRUCTURE; Chemical Agents Disrupting the Serum Amyloid P Component; Monoclonal Antibody Treatment of Amyloidosis; CONCLUSION; REFERENCES Chapter 4 Adiposopathy Harold E. Bays and J. Michael Gonzalez-Campoy |
| Record Nr. | UNINA-9910465488703321 |
| New Jersey, : World Scientific, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New-opathies [[electronic resource] ] : an emerging molecular reclassification of human disease / / [edited by] Errol C. Friedberg ... [et al.]
| New-opathies [[electronic resource] ] : an emerging molecular reclassification of human disease / / [edited by] Errol C. Friedberg ... [et al.] |
| Pubbl/distr/stampa | New Jersey, : World Scientific, c2012 |
| Descrizione fisica | 1 online resource (310 p.) |
| Disciplina | 616.001/2 |
| Altri autori (Persone) | FriedbergErrol C |
| Soggetto topico |
Diseases
Medical genetics Nosology |
| ISBN |
1-283-59369-6
9786613906144 981-4355-69-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Preface; Acknowledgements; List of Contributors; Chapter 1 Laminopathies William T. Dauer and Howard J.Worman; NEW "OPATHIES" FOR A NEW MILLENNIUM; THE NUCLEAR ENVELOPE: NORMAL STRUCTURE AND COMPOSITION; LAMINOPATHIES; Laminopathies Caused by Mutations in LMNA; Striated muscle diseases; Lipodystrophy syndromes; Peripheral neuropathy; Progeroid syndromes; Laminopathies Caused by Mutations Affecting B-Type Lamins; Mutations in Genes Encoding Nuclear Membrane Proteins; Inner nuclear membrane; Perinuclear space; Outer nuclear membrane
Mutations in Genes Encoding Nuclear Pore Complex ProteinsCONCLUSION; REFERENCES; Chapter 2 Inflammasomopathies: Diseases Linked to the NLRP3 Inflammasome Dominic De Nardo, Johanna Vogelhuber, Larisa Labzin, Pia Langhoff and Eicke Latz; INTRODUCTION AND OVERVIEW; THE NLRP3 INFLAMMASOME: A PLATFORM FOR MATURATION OF IL-1 βFAMILY CYTOKINES; NOD-Like Receptors (NLRs); Inflammasome-Forming Proteins; Focus on the NLRP3 Inflammasome; INFLAMMASOMOPATHIES: THE NLRP3 INFLAMMASOME AND DISEASE; Genetic NLRP3 Inflammasome Disorders; Cryopyrin-associated periodic syndromes (CAPS) Clinical manifestation of CAPS diseasesFamilial cold autoinflammatory syndrome (FCAS); Muckle-Wells syndrome (MWS); Neonatal onset multisystem inflammatory disease (NOMID); Genetics of CAPS; Mechanism of inflammasome activation in CAPS; The NLRP3 Inflammasome and Environmental Diseases; Silicosis and asbestosis; Nanoparticles; The NLRP3 Inflammasome in Infectious Diseases; Influenza A virus; Malaria; The NLRP3 Inflammasome in Metabolic Diseases; Gout and pseudogout; Alzheimer's disease; Atherosclerosis; Obesity and early type 2 diabetes (T2D); Type 2 diabetes progression CURRENT THERAPEUTIC STRATEGIES TARGETING INFLAMMASOMOPATHIESCONCLUDING REMARKS; REFERENCES; Chapter 3 Amyloidosis Morie A. Gertz; INTRODUCTION; PATHOGENESIS; AMYLOID ORGAN INVOLVEMENT; DIAGNOSIS; SCREENING FOR AMYLOIDOSIS; CONFIRMING THE DIAGNOSIS; IMAGING OF AMYLOIDOSIS; CLINICAL CLASSIFICATIONS OF AMYLOIDOSIS; Immunoglobulin Light Chain Amyloidosis (AL); Secondary Systemic Amyloidosis (AA); Familial Amyloidosis; Transthyretin; Nontransthyretin Forms of Familial Amyloidosis; Native Transthyretin Amyloidosis (Senile Cardiac Amyloidosis); Localized Amyloidosis Amyloidosis of the Renal Pelvis, Ureter, Bladder, and UrethraTracheobronchial Tree and Laryngeal Amyloid; SKIN; THERAPY; Treatment Overview; Alkylator-based Therapy; Stem Cell Transplantation; Novel-Agent-Containing Regimens; Thalidomide; Lenalidomide; Bortezomib; Pomalidomide; THERAPY OF SECONDARY AMYLOIDOSIS; TRANSPLANTATION FOR FAMILIAL AMYLOIDOSIS; AGENTS THAT DESTABILIZE THE AMYLOID PROTEIN STRUCTURE; Chemical Agents Disrupting the Serum Amyloid P Component; Monoclonal Antibody Treatment of Amyloidosis; CONCLUSION; REFERENCES Chapter 4 Adiposopathy Harold E. Bays and J. Michael Gonzalez-Campoy |
| Record Nr. | UNINA-9910792082303321 |
| New Jersey, : World Scientific, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New-opathies [[electronic resource] ] : an emerging molecular reclassification of human disease / / [edited by] Errol C. Friedberg ... [et al.]
| New-opathies [[electronic resource] ] : an emerging molecular reclassification of human disease / / [edited by] Errol C. Friedberg ... [et al.] |
| Pubbl/distr/stampa | New Jersey, : World Scientific, c2012 |
| Descrizione fisica | 1 online resource (310 p.) |
| Disciplina | 616.001/2 |
| Altri autori (Persone) | FriedbergErrol C |
| Soggetto topico |
Diseases
Medical genetics Nosology |
| ISBN |
1-283-59369-6
9786613906144 981-4355-69-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Preface; Acknowledgements; List of Contributors; Chapter 1 Laminopathies William T. Dauer and Howard J.Worman; NEW "OPATHIES" FOR A NEW MILLENNIUM; THE NUCLEAR ENVELOPE: NORMAL STRUCTURE AND COMPOSITION; LAMINOPATHIES; Laminopathies Caused by Mutations in LMNA; Striated muscle diseases; Lipodystrophy syndromes; Peripheral neuropathy; Progeroid syndromes; Laminopathies Caused by Mutations Affecting B-Type Lamins; Mutations in Genes Encoding Nuclear Membrane Proteins; Inner nuclear membrane; Perinuclear space; Outer nuclear membrane
Mutations in Genes Encoding Nuclear Pore Complex ProteinsCONCLUSION; REFERENCES; Chapter 2 Inflammasomopathies: Diseases Linked to the NLRP3 Inflammasome Dominic De Nardo, Johanna Vogelhuber, Larisa Labzin, Pia Langhoff and Eicke Latz; INTRODUCTION AND OVERVIEW; THE NLRP3 INFLAMMASOME: A PLATFORM FOR MATURATION OF IL-1 βFAMILY CYTOKINES; NOD-Like Receptors (NLRs); Inflammasome-Forming Proteins; Focus on the NLRP3 Inflammasome; INFLAMMASOMOPATHIES: THE NLRP3 INFLAMMASOME AND DISEASE; Genetic NLRP3 Inflammasome Disorders; Cryopyrin-associated periodic syndromes (CAPS) Clinical manifestation of CAPS diseasesFamilial cold autoinflammatory syndrome (FCAS); Muckle-Wells syndrome (MWS); Neonatal onset multisystem inflammatory disease (NOMID); Genetics of CAPS; Mechanism of inflammasome activation in CAPS; The NLRP3 Inflammasome and Environmental Diseases; Silicosis and asbestosis; Nanoparticles; The NLRP3 Inflammasome in Infectious Diseases; Influenza A virus; Malaria; The NLRP3 Inflammasome in Metabolic Diseases; Gout and pseudogout; Alzheimer's disease; Atherosclerosis; Obesity and early type 2 diabetes (T2D); Type 2 diabetes progression CURRENT THERAPEUTIC STRATEGIES TARGETING INFLAMMASOMOPATHIESCONCLUDING REMARKS; REFERENCES; Chapter 3 Amyloidosis Morie A. Gertz; INTRODUCTION; PATHOGENESIS; AMYLOID ORGAN INVOLVEMENT; DIAGNOSIS; SCREENING FOR AMYLOIDOSIS; CONFIRMING THE DIAGNOSIS; IMAGING OF AMYLOIDOSIS; CLINICAL CLASSIFICATIONS OF AMYLOIDOSIS; Immunoglobulin Light Chain Amyloidosis (AL); Secondary Systemic Amyloidosis (AA); Familial Amyloidosis; Transthyretin; Nontransthyretin Forms of Familial Amyloidosis; Native Transthyretin Amyloidosis (Senile Cardiac Amyloidosis); Localized Amyloidosis Amyloidosis of the Renal Pelvis, Ureter, Bladder, and UrethraTracheobronchial Tree and Laryngeal Amyloid; SKIN; THERAPY; Treatment Overview; Alkylator-based Therapy; Stem Cell Transplantation; Novel-Agent-Containing Regimens; Thalidomide; Lenalidomide; Bortezomib; Pomalidomide; THERAPY OF SECONDARY AMYLOIDOSIS; TRANSPLANTATION FOR FAMILIAL AMYLOIDOSIS; AGENTS THAT DESTABILIZE THE AMYLOID PROTEIN STRUCTURE; Chemical Agents Disrupting the Serum Amyloid P Component; Monoclonal Antibody Treatment of Amyloidosis; CONCLUSION; REFERENCES Chapter 4 Adiposopathy Harold E. Bays and J. Michael Gonzalez-Campoy |
| Record Nr. | UNINA-9910819000203321 |
| New Jersey, : World Scientific, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||